Cargando…

Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males

PURPOSE: Endoscopic lasers have become a treatment option for benign prostate hyperplasia (BPH). The study reported here sought to elucidate the benefits and drawbacks of different laser systems in the treatment of patients with BPH. METHODS: The study enrolled 741 patients diagnosed with lower urin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Wei-Chang, Lin, Yu-Hsiang, Hou, Chen-Pang, Chang, Phei-Lang, Chen, Chien-Lun, Juang, Horng-Heng, Tsui, Ke-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832386/
https://www.ncbi.nlm.nih.gov/pubmed/24255595
http://dx.doi.org/10.2147/CIA.S52697
_version_ 1782291668423147520
author Lee, Wei-Chang
Lin, Yu-Hsiang
Hou, Chen-Pang
Chang, Phei-Lang
Chen, Chien-Lun
Juang, Horng-Heng
Tsui, Ke-Hung
author_facet Lee, Wei-Chang
Lin, Yu-Hsiang
Hou, Chen-Pang
Chang, Phei-Lang
Chen, Chien-Lun
Juang, Horng-Heng
Tsui, Ke-Hung
author_sort Lee, Wei-Chang
collection PubMed
description PURPOSE: Endoscopic lasers have become a treatment option for benign prostate hyperplasia (BPH). The study reported here sought to elucidate the benefits and drawbacks of different laser systems in the treatment of patients with BPH. METHODS: The study enrolled 741 patients diagnosed with lower urinary tract symptoms secondary to BPH during the period January 2005 to December 2011. The techniques used in the study were photoselective vaporization of the prostate, thulium laser prostatectomy, and diode laser prostatectomy. Patients were assigned to one of three groups according to the type of laser treatment they received. Outcomes were evaluated using the International Prostate Symptom Score (IPSS), quality of life, maximal urinary flow rate, post-voiding residual urine volume, and prostate-specific antigen (PSA) level. RESULTS: The baseline characteristics of patients who received diode laser prostatectomy show a significant elevated risk and high American Society of Anesthesiology score (P=0.001). Operative time and catheter removal time differed significantly between the three groups (P=0.001). No cases were converted to transurethral resection of the prostate intraoperatively due to bleeding (P=0.142). Among the three groups, there were no significant differences in maximal flow rate, lower post-void residual urine, and postoperative PSA level during the entire follow-up period (P<0.05). Further, no significant differences in postoperative IPSS, quality of life, or bladder neck contracture (P=0.23) were observed. However, a significant difference was observed with regard to prolonged use of Foley catheters and prolonged hospital stay among patients in the diode laser group (P=0.001). CONCLUSION: Laser prostatectomies are effective in dealing with lower urinary tract symptoms. Early subjective functional results (maximal flow rate, IPSS, and post-void residual urine) appeared the same as those obtained following laser prostatectomy. Thus, it appears that lasers are safe and effective as long as the patients are carefully selected for treatment.
format Online
Article
Text
id pubmed-3832386
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-38323862013-11-19 Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males Lee, Wei-Chang Lin, Yu-Hsiang Hou, Chen-Pang Chang, Phei-Lang Chen, Chien-Lun Juang, Horng-Heng Tsui, Ke-Hung Clin Interv Aging Original Research PURPOSE: Endoscopic lasers have become a treatment option for benign prostate hyperplasia (BPH). The study reported here sought to elucidate the benefits and drawbacks of different laser systems in the treatment of patients with BPH. METHODS: The study enrolled 741 patients diagnosed with lower urinary tract symptoms secondary to BPH during the period January 2005 to December 2011. The techniques used in the study were photoselective vaporization of the prostate, thulium laser prostatectomy, and diode laser prostatectomy. Patients were assigned to one of three groups according to the type of laser treatment they received. Outcomes were evaluated using the International Prostate Symptom Score (IPSS), quality of life, maximal urinary flow rate, post-voiding residual urine volume, and prostate-specific antigen (PSA) level. RESULTS: The baseline characteristics of patients who received diode laser prostatectomy show a significant elevated risk and high American Society of Anesthesiology score (P=0.001). Operative time and catheter removal time differed significantly between the three groups (P=0.001). No cases were converted to transurethral resection of the prostate intraoperatively due to bleeding (P=0.142). Among the three groups, there were no significant differences in maximal flow rate, lower post-void residual urine, and postoperative PSA level during the entire follow-up period (P<0.05). Further, no significant differences in postoperative IPSS, quality of life, or bladder neck contracture (P=0.23) were observed. However, a significant difference was observed with regard to prolonged use of Foley catheters and prolonged hospital stay among patients in the diode laser group (P=0.001). CONCLUSION: Laser prostatectomies are effective in dealing with lower urinary tract symptoms. Early subjective functional results (maximal flow rate, IPSS, and post-void residual urine) appeared the same as those obtained following laser prostatectomy. Thus, it appears that lasers are safe and effective as long as the patients are carefully selected for treatment. Dove Medical Press 2013 2013-11-04 /pmc/articles/PMC3832386/ /pubmed/24255595 http://dx.doi.org/10.2147/CIA.S52697 Text en © 2013 Lee et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Lee, Wei-Chang
Lin, Yu-Hsiang
Hou, Chen-Pang
Chang, Phei-Lang
Chen, Chien-Lun
Juang, Horng-Heng
Tsui, Ke-Hung
Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
title Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
title_full Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
title_fullStr Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
title_full_unstemmed Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
title_short Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
title_sort prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832386/
https://www.ncbi.nlm.nih.gov/pubmed/24255595
http://dx.doi.org/10.2147/CIA.S52697
work_keys_str_mv AT leeweichang prostatectomyusingdifferentlasersforthetreatmentofbenignprostatehyperplasiainagingmales
AT linyuhsiang prostatectomyusingdifferentlasersforthetreatmentofbenignprostatehyperplasiainagingmales
AT houchenpang prostatectomyusingdifferentlasersforthetreatmentofbenignprostatehyperplasiainagingmales
AT changpheilang prostatectomyusingdifferentlasersforthetreatmentofbenignprostatehyperplasiainagingmales
AT chenchienlun prostatectomyusingdifferentlasersforthetreatmentofbenignprostatehyperplasiainagingmales
AT juanghorngheng prostatectomyusingdifferentlasersforthetreatmentofbenignprostatehyperplasiainagingmales
AT tsuikehung prostatectomyusingdifferentlasersforthetreatmentofbenignprostatehyperplasiainagingmales